Breaking AI & Tech News Analyzed

Prominent Kashmiri separatist Aasiya Andrabi has been handed down three life sentences by an Indian court, a move that has been widely condemned by activists and legal experts. Andrabi, the founder of the banned all-women's organisation Dukhtaran-e-Millat (DeM), was sentenced on March 24 by a special National Investigative Agency (NIA) court in New Delhi.Andrabi, 64, and her two associates, Sofi Fehmeeda and Nahida Nasreen, were arrested by the NIA in 2018 under the Unlawful Activities Prevention Act (UAPA), a draconian anti-terror law. The UAPA was introduced in 2008 and amended in 2019 to allow authorities to declare individuals as 'terrorists'. Andrabi was accused of waging war against the Indian government, raising funds for terrorist acts, and being a member of a terrorist group.However, the court found no evidence related to these charges, yet convicted her on less serious allegations such as provoking hostility between communities and undermining national integration. The court noted that while Andrabi's actions did not directly cause violence, they could evoke sentiments that may lead to violence.Legal experts say Andrabi's conviction is mainly based on offensive speech-making, raising questions about India's tolerance of dissenting voices. 'Ideology is not punishable by law; only actions are,' a Kashmir-based legal researcher said. 'But the UAPA's scope has been widened significantly through several amendments.'Andrabi's son described the conviction as 'effectively a death sentence' given her age and time already spent in jail. Her husband, a former rebel leader, has also been imprisoned since 1992. Critics argue that the conviction fits a broader pattern in which all forms of political resistance are disciplined in Kashmir.

As the cost of living crisis continues to bite, finding ways to lower your grocery bill has become more important than ever. Retail workers are sharing their insider knowledge on how to save money at supermarkets, street markets, and charity shops.Be Savvy About Store DiscountsMany supermarkets offer yellow-stickered items that are reduced in price due to nearing their expiration dates. These discounts can be significant, with reductions of up to 75% off. Alasdair Baker, who runs The Penny Pincher, advises shopping for these items in the late afternoon or early evening when the biggest reductions are typically applied.View image in fullscreenTiming matters … you’ll find the biggest reductions on yellow-sticker items in the late afternoon and early evening. Be AppySome grocery stores use apps such as Too Good To Go and Olio to offer discounts or free food to avoid food waste – but it can be a gamble as to what you get.Use Common SenseIf you buy something reduced on the day it is expiring, that doesn’t mean you need to eat it that day. There is a difference between “best before” dates, which are about food quality and the more important “use by” dates, which are about food safety.Be Cautious About ‘Bogof’ Deals“There aren’t as many buy one, get one free [bogof] deals now, because of new rules that came into place last year,” says Baker. These restrict promotions of products high in fat, sugar or salt.Avoid Big BrandsThe ends of supermarket aisles often feature big brands, says Baker. “They are not placed there randomly: the companies pay an awful lot of money. The idea is to try to coax people into buying those products more often.”Sign Up for a Store Card“It’s sad that we now have to essentially sell our data to the supermarkets in exchange for affordability – but such is life in 2026,” says Jenny Rogers. “If you have a store card, it is also worth getting the supermarket app, as a lot of stores will give you one or two personalised offers a week, or periodic free delivery for members.

Cameron Picton, the bassist‑vocalist behind British art‑rock outfit Black Midi, has unveiled his first solo statement under the moniker My New Band Believe. Recorded with a cadre of improvisational musicians—including veteran drummer Steve Noble, formerly of Rip Rig + Panic—the album abandons the band’s signature wall of sound for an intimate, acoustic approach.The record opens with the gentle ballad “Still,” a track originally tucked away on Black Midi’s sprawling rock‑opera Hellfire. Here, Picton’s unadorned vocal delivery replaces Geordie Greep’s theatrical croons, setting a tone of understated sincerity that runs through the entire project.Every song is built from live‑sounding instruments: fingerpicked guitars, double bass, piano, subtle percussion and tasteful string arrangements. This stripped‑back aesthetic allows the lyrics to move away from Black Midi’s often surreal narratives toward more direct, everyday subjects. For instance, the opening track “Target Practice” retains a hint of the band’s dark humor, while “Love Story” paints a nostalgic picture of a couple cooking together, and “Opposite Teacher” reflects on the challenges of fatherhood.Even within this quieter framework, Picton injects moments of tension. The second track, “In the Blink of an Eye,” introduces dissonant chords that remind listeners that “understated” is a relative term for an artist accustomed to sonic extremes. Throughout, the songs remain episodic, with sudden key changes and tempo shifts that echo the restless spirit of Van Dyke Parks’ 1967 Song Cycle—a collaboration Picton initially pursued before budget constraints halted the partnership.Highlights such as “Heart of Darkness” weave together folk‑rock riffs, jazzy drumming and an improvised coda of feedback‑like strings, while “Actress” balances sweet melodies with dramatic pauses and volume surges, ending more as a gradual fade than a conventional finish.Compared with Black Midi’s recent releases—most notably the chaotic, genre‑bending Hellfire and Geordie Greep’s solo effort The New Sound—Picton’s debut feels more approachable without sacrificing artistic curiosity. The album’s constant motion is contained by its acoustic instrumentation, making it easier to love rather than merely admire. It resists standard song structures, defies easy categorisation, and showcases a plethora of unconventional musical ideas, all while wearing its intelligence with a lighter touch.

For the first time, scientists have observed a 'civil war' in wild chimpanzees, where a once unified group turned on itself, leading to a years-long conflict. In a study published in the journal Science, researchers detail the dramatic shift in behavior among the Ngogo chimpanzee group in Uganda's Kibale national park.Primatologist Aaron Sandel, who led the research, noted that the conflict began in 2015 when the group's dynamics started to change. A change in social hierarchies, the death of key older individuals, and a disease outbreak in 2017 contributed to the group's fracture. By 2018, two distinct groups had emerged: the western chimps and the central chimps.The conflict escalated into 24 sustained and coordinated attacks by the western group on the central group over seven years, resulting in the deaths of at least seven adult males and 17 infants. This level of in-group violence is rare in the animal kingdom and has significant implications for understanding human conflict.Sandel suggests that human activities disrupting social cohesion, such as deforestation, climate change, or disease outbreaks, could make such inter-group conflicts more common among chimpanzees, who are already threatened with extinction. The study highlights the fragility of social ties and the potential for group cohesion to be disrupted under specific circumstances.Brian Wood, an evolutionary anthropologist, noted that the western chimps increased their Darwinian fitness by decreasing the survival and reproduction of their former community members. This conflict has resulted in the lowest survivorship ever documented in a wild chimpanzee community.

Matthew Macfadyen headlines the new Sky Atlantic series ‘The Miniature Wife’, playing scientist Les Littlejohn, a brilliant but ethically dubious researcher who accidentally shrinks his wife Lindy (Elizabeth Banks) to six inches tall. The premise promises a darkly comic exploration of marital power dynamics and modern misogyny. However, the show quickly abandons this fertile ground. Showrunners Jennifer Ames and Steve Turner opt for a frenetic, screwball tone that feels forced, leaving the underlying commentary underdeveloped. The central conceit – a miniature wife trapped in a dollhouse – is treated more as a visual gag than a vehicle for satire. The series is littered with side plots that never coalesce. A subplot about a misattributed short story attempts to touch on authorship and truth in the digital age, yet it remains a superficial gesture. Likewise, the ensemble cast—including Zoe Lister‑Jones as a lab overseer, O‑T Fagbenle as a lovelorn colleague, and Sian Clifford as Lindy’s agent—offers colorful moments but fails to achieve narrative momentum. Visually, the production delivers inventive set pieces: Lindy’s daring escapes from towering household objects and explosive laboratory experiments provide occasional laughs. Nevertheless, the novelty wears thin before the series’ nearly ten‑hour runtime concludes. The original short story by Manuel Gonzales required far more expansion than the show supplies, resulting in a stretched‑out narrative that would have benefited from a tighter format. In short, while Macfadyen’s performance is competent, it is largely wasted in a series that promises depth but delivers only scattered comedy. ‘The Miniature Wife’ may satisfy viewers seeking light‑hearted antics, but it falls short of the incisive satire its premise suggests. The series is available on Sky Atlantic, streaming on Now in the UK and on Stan in Australia.

The ceasefire deal between Iran and the US has been hailed as a significant achievement for China, which has been actively working to promote de-escalation and an end to hostilities in the region. Beijing's powerbrokers are being credited with pushing Iran towards agreeing to the ceasefire, bolstering its status as a regional mediator.In China's tightly censored domestic media, articles basking in the glory of China being the grown-up in the room at a time of international crisis were allowed to circulate. China's role in the negotiations was confirmed by US President Donald Trump, who told the Agence France-Presse news agency that he believed China had got Iran to agree to a ceasefire.However, some analysts are sceptical about how influential China could actually have been in the late-night discussions. The deal is advantageous to Iran, and encouraging the regime to agree to it would have been like 'pushing an open door', according to one analyst. Nicholas Lyall, a senior researcher at Trends, a research and advisory firm in Abu Dhabi, said: 'In terms of whether China had to do much pushing of Iran for it to agree to the temporary ceasefire, and whether Iran was swayed by this reported Chinese effort, it's essential to clarify what Iran has actually agreed to.'Officially, China has not confirmed or denied reports that it played an active role in the Islamabad negotiations. At a press conference on Wednesday, the foreign ministry spokesperson Mao Ning said only that China 'had been actively working to promote de-escalation and an end to all hostilities'. China's economic interests are also at stake, as the risk of a global recession and soaring fossil fuel prices poses a threat to the Chinese economy, which is heavily dependent on exports.Analysts are even more sceptical of the idea that China might act as the guarantor of any ceasefire agreement in the Middle East. Song Bo, a fellow at the Center for International Security and Strategy at Tsinghua University, said: 'China doesn't have a direct stake with any of the parties in the Middle East. Acting as a guarantor for a ceasefire would be an extremely high-cost diplomatic undertaking, and I don't think China would commit to that easily.'

A 47‑year‑old woman who had endured three life‑threatening autoimmune diseases for more than a decade is now living a near‑normal life after an experimental CAR‑T cell therapy reset her immune system at University Hospital Erlangen in Germany.Before the procedure she had exhausted nine different treatments with no lasting benefit, relying on daily blood transfusions and continuous anticoagulation to manage her illnesses.Within weeks of the infusion, doctors observed rapid improvement in all three conditions—a world‑first outcome. She has remained in treatment‑free remission for 14 months and has largely returned to everyday activities.Prof Fabian Müller, who led the team, called the speed and depth of the response “remarkable” and said the therapy “significantly improved her quality of life.” He emphasized that clinical trials are required to determine how durable the effect is and whether it can help other autoimmune patients.The patient suffered from three distinct disorders: autoimmune haemolytic anaemia (AIHA), where rogue immune cells destroy red blood cells; immune thrombocytopenia (ITP), which depletes platelets and raises bleeding risk; and antiphospholipid syndrome (APS), which promotes dangerous blood clots. All three stem from malfunctioning B‑cells.With no conventional options left, doctors turned to CAR‑T therapy, a technique that has revolutionised treatment for certain cancers. They harvested her white‑blood cells, isolated the T‑cells, engineered them to recognise the CD19 protein on B‑cells, and reinfused the modified cells.The engineered T‑cells swiftly eliminated the pathogenic B‑cells. She received her last blood transfusion a week after treatment and was able to perform routine tasks within two weeks. Follow‑up tests showed a reconstituted, healthy B‑cell population, suggesting an immune reset. The findings were published in the journal Med.She still exhibits a mildly low white‑cell count and slightly elevated liver enzymes, which researchers attribute to the cumulative impact of prior therapies rather than the CAR‑T product.Rheumatology expert Prof Ben Parker of Manchester University NHS Foundation Trust described the case as encouraging, noting that “the prolonged response off normal therapy suggests there has been an immune reset.” However, he warned that case reports alone cannot confirm efficacy and highlighted ongoing trials for lupus, myositis, multiple sclerosis, systemic sclerosis, vasculitis, and other autoimmune conditions.

Israeli air raids have torn through densely populated commercial and residential districts in central Beirut without warning, striking the heart of the capital just hours after a ceasefire was announced in the United States-Israeli war with Iran.Lebanon’s Ministry of Public Health reported that dozens of people had been killed and hundreds wounded, stressing that the figures were preliminary and likely to rise as rescue workers sifted through the rubble.Israel had already claimed that the truce did not apply to its conflict with Hezbollah in Lebanon, despite mediator Pakistan saying the agreement extended to that front as well.The Israeli military described the bombardment as the largest coordinated strike of the current war, with more than 100 Hezbollah-linked targets hit within 10 minutes in Beirut, southern Lebanon and the eastern Bekaa Valley.Several of the strikes landed in busy commercial areas, sending residents fleeing in panic as sirens wailed and glass and debris carpeted the streets.Lebanon’s National News Agency said at least five neighbourhoods in Beirut’s central and coastal districts were hit.The Israeli military said it had targeted missile launchers, command centres and intelligence infrastructure, and accused Hezbollah of using civilians as human shields.Residents and local officials, however, insisted that the buildings struck were not military sites.While Israel has regularly bombed southern and eastern Lebanon, as well as Hezbollah strongholds in Beirut’s southern suburbs, it had rarely carried out attacks in central Beirut since the latest round of fighting with the group began on March 2.Israeli air strikes in Lebanon have killed more than 1,530 people so far, and have forced at least 1.2 million people to flee their homes.

Researchers have made a significant breakthrough in understanding why weight-loss medications, such as GLP1 receptor agonists, work better for some individuals than others. A recent study published in Nature has identified genetic variations in two genes involved in gut hormone pathways that regulate appetite and digestion. These genetic variations may help account for different weight-loss results or side-effects when taking glucagon-like peptide 1 (GLP1) medicines, which mimic natural gut hormones to regulate appetite, insulin release, and digestion. The study analyzed data from 27,885 patients on GLP1 drugs and found that specific genetic variants were associated with slightly more weight loss or side-effects like nausea and vomiting. The findings suggest that genetic differences may contribute to why people respond differently to weight-loss jabs. However, the overall impact of genetics appeared to be modest, with non-genetic factors such as sex, drug type, dose, and duration appearing to explain a substantially larger proportion of variability. The study's results reinforce that while there is substantial variability in response to GLP1 therapies, genetics is only one part of a much more complex picture. According to Marie Spreckley, an obesity expert at the University of Cambridge, the study provides plausible evidence that genetic variants could affect outcomes. However, she notes that the magnitude of these genetic effects is small in clinical terms, and that behavioral, clinical, and treatment-related factors remain the dominant drivers of outcomes. The study's authors suggest that their findings could support future efforts to use genetic information when making treatment choices for obesity. However, Spreckley cautions that the evidence is not yet sufficient to support using genetic information to guide treatment decisions in routine clinical practice.